Yoshihiro Kameoka1, Atsushi Kitabayashi2, Kumi Ubukawa1, Shinsuke Noguchi3, Hideaki Ohyagi4, Mutsuhito Motegi5, Yoshinari Kawabata2, Jin Ogasawara6, Jun Kuroki7, Takashi Nimura5, Naoto Takahashi1 (1.Hematol., Akita Univ., Akita, Japan, 2.Hematol., Akita Kousei Med. Cen., Akita, Japan, 3.Hematol., Akita Red Cross Hosp., Akita, Japan, 4.Hematol., Hiraka Gen. Hosp., Yokote, Japan, 5.Int., Med., Omagari Kousei Med. Cen., Omagari, Japan, 6.Int., Med., Odate Municipal Gen. Hosp., Odate, Japan, 7.Int., Med., Yuri Kumiai Gen. Hosp., Yurihonjo, Japan)
Session information
Oral Session
Oral Session 2-7D Indolent Lymphoma: Novel Therapy
Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.7 (Tokyo International Forum, 5F Hall D5)
Chair: Wataru Munakata (Department of Hematology, National Cancer Center Hospital)
Ami Fukumoto, Kentaro Narita, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Akihiro Kitadate, Masami Takeuchi, Kosei Matsue (Hematology, Kameda Medical Center, Chiba, Japan)
Hiroto Adachi, Yusuke Kanemasa, Shohei Nakamura, Toshihiro Okuya, Akihiko Kageyama, Chikako Funasaka, Tatsu Shimoyama, Yasushi Omuro (Medical Oncology, Komagome Hospital, Tokyo, Japan)
Mizuki Hyuga, Yusuke Koba, Naoko Hiranuma, Kensuke Fujiwara, Kazuhiro Bandai, Takahito Kawata, Naoya Ukyo, Akira Tamekane, Mitsumasa Watanabe (Hematol, Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan)
Kohei Tada, Naoki Yuhi, Yuki Oku, Chika Yamada, Tomohiro Taya, Hirotaka Nakamura, Noriko Sugino, Masaharu Tashima, Hitomi Kaneko, Kazuo Hatanaka, Chisato Mizutani, Kazunori Imada (Department of Hematology, Osaka Red Cross Hospital, Osaka, Japan)
Keiichi Uchida1, Harumi Kato1, Masamitsu Yanada1, Hirofumi Taji1, Toko Saito1, Shoichi Kato2, Yasushi Yatabe2, Kazuhito Yamamoto1 (1.Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, 2.Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital)